drugset
drugset / Trial / NCT02335255

Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis

NCT02335255 ↗

Phase 1 Completed 1519 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the efficacy and safety of the test formulation Naftifine Hydrochloride Gel 2% to Naftin® (Naftifine Hydrochloride) Gel 2%

Timeline

Start
2014-06-27
Primary completion
2018-05-15
Completion
2018-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Naftifine Other / unclassified 2 % Topical

Indications

tinea pedis